Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world, Multi-center, Prospective, Observational Study for Paroxysmal Nocturnal Haemoglobinuria (PNH) in China

NCT06154512 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06154512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06154512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world, Multi-center, Prospective, Observational Study for Paroxysmal Nocturnal Haemoglobinuria (PNH) in China
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 10, 2023
Completion date
December 3, 2025
Enrollment
724 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal nocturnal hemoglobinuria